Experiment 363049

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismHypericum perforatum (CLUSIACEAE)
CitationHARRER,G: HUBNER,WD: PODZUWEIT,H:. (1994). EFFECTIVENESS AND TOLERANCE OF THE HYPERICUM EXTRACT LI 160 COMPARED TO MAPROTILINE: A MULTICENTER DOUBLE-BLIND STUDY.. 7(1)
Amount utilized
Compound isolated
DiseaseA RANDOMIZED, DOUBLE-BLIND STUDY EXAMINING THE EFFECTIVENESS AND TOLERANCE OF A STANDARDIZED HYPERICUM PREPARATION WHEN COMPARED TO MAPROTILINE WAS PERFORMED IN A GROUP OF 102 PATIENTS WITH DEPRESSION, IN ACCORDANCE WITH ICD-10, F 32.1. THE STUDY WAS CONDUCTED IN THE OFFICES OF NEUROLOGY AND PSYCHIATRY SPECIALISTS. THE PATIENTS RECEIVED, OVER A PERIOD OF 4 WEEKS. EITHER 3 X 300 MG OF THE PHYERICUM EXTRACT OR 3 X 25 MG MAPROTILINE PILLS OF IDENTICAL APPEARANCE. EFFECTIVENESS WAS DETERMINED USING THE HAMILTON DEPRESSION SCALE (HAMD), THE DEPRESSION SCALE ACCORDING TO VON ZERSSEN (D-S), AND THE CLINICAL GLOBAL IMPRESSION SCALE (CGI). THE TOTAL SCORE OF THE HAMD SCALE DROPPED DURING THE 4 WEEKS OF THERAPY IN BOTH TREATMENT GROUPS BY ABOUT 50%. THE MEAN VALUES OF THE D-S SCALE AND THE CGI SCALE SHOWED SIMILAR RESULTS, AND AFTER 4 WEEKS OF THERAPY, NO SIGNIFICANT DIFFERENCES IN EITHER TREATMENT GROUP WERE NOTICED.
Dose amount900.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT
GenderGIVEN TO BOTH SEXES